You are here: Industry Insights > COVID-19

News List

Research shows Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19 prnasia
December 10, 2021
Lianhua Qingwen capsules conferred preventive effects on those exposed to COVID-19", claimed an article titled "Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019...
Global Millet Seeds Market Expected to Generate a Revenue of $5,51,469.70 Thousand by 2028, Growing at a CAGR of 6.0% from 2021 to 2028 - Exclusive COVID-19 Impact Analysis Report by Research Dive prnewswire
December 10, 2021
Research Dive has added a new report to its offering titled, "Millet Seeds Market by Type (Pearl Millet, Finger Millet, Proso Millet, Foxtail Millet, and Others), Sales Channel (Specialty Stores, Online Channels, and Others)...
FXB Center for Health and Human Rights at Harvard University Joins Project N95 and Boston University To Distribute 20,000 Masks to Massachusetts Community Groups Amid Surging COVID-19 Cases prnewswire
December 10, 2021
In response to surging COVID-19 cases in Massachusetts, the FXB Center for Health and Human Rights joined national non-profit Project N95 and the Boston University School of Public Health...
Effectiveness of mRNA COVID-19 Vaccines Lower at ≥120 Days Drugs
December 10, 2021
The vaccine effectiveness (VE) of both the Moderna and Pfizer-BioNTech mRNA vaccines declined at ≥120 days after the second dose, with higher VE and antibody levels for Moderna than Pfizer-BioNTech recipients...
FDA Approves Pfizer Boosters for Teens Aged 16 to 17 Drugs
December 10, 2021
The U.S. Food and Drug Administration on Thursday approved the emergency use of the Pfizer COVID-19 booster shots for Americans aged 16 and 17 years old.
FDA grants EUA to AstraZeneca’s antibody therapy for Covid-19 prevention Pharmaceutical-Technology
December 10, 2021
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for AstraZeneca’s antibody therapy Evusheld for the pre-exposure prophylaxis or to prevent Covid-19.
China approves Brii Bio’s antibody combination therapy for Covid-19 Pharmaceutical-Technology
December 10, 2021
The National Medical Products Administration (NMPA) of China has approved Brii Biosciences’ amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy to treat individuals...
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001 AmericanPharmaceuticalReview
December 09, 2021
Valneva SE announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the Company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured...
Revealed: How SARS-CoV-2 evades our immune system WorldPharmaNews
December 09, 2021
Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.
Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19 AmericanPharmaceuticalReview
December 09, 2021
Sosei Group Corporation announced it has received grant funding from Wellcome, through the COVID-19 Therapeutics Accelerator. The funding will be used to advance the pre-clinical development of the Company's novel oral anti-viral small molecules ...